financetom
Business
financetom
/
Business
/
--Flowco Keeps Quarterly Dividend at $0.08 per Share, Payable Aug. 29 to Holders of Record on Aug. 15
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Flowco Keeps Quarterly Dividend at $0.08 per Share, Payable Aug. 29 to Holders of Record on Aug. 15
Aug 1, 2025 6:58 AM

09:38 AM EDT, 08/01/2025 (MT Newswires) --

Price: 18.27, Change: -0.39, Percent Change: -2.09

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pason Systems Removed from RBC Capital Markets' Global Energy Best Ideas List
Pason Systems Removed from RBC Capital Markets' Global Energy Best Ideas List
Nov 4, 2024
10:25 AM EST, 11/04/2024 (MT Newswires) -- Pason Systems ( PSYTF ) -- due to release 2024 Q3 results On November 7, 2024 -- was removed from RBC Capital Markets' Global Energy Best Ideas list due to reduced near-term catalysts resulting from flatter US rig and frac count trajectory, RBC said in a Monday note. We still believe the company...
Health Solutions Provider Owens & Minor's Q3 Earnings: Revenue And EPS Beat, Trims Annual Outlook
Health Solutions Provider Owens & Minor's Q3 Earnings: Revenue And EPS Beat, Trims Annual Outlook
Nov 4, 2024
On Monday, Owens & Minor Inc. ( OMI ) reported the third quarter of 2024 adjusted EPS of $0.42, down from $0.44 reported a year ago, beating the consensus of $0.41. The company reported sales of $2.72 billion, up 5% year-over-year, beating the consensus of $2.68 billion. Patient Direct revenue of $687 million, up 6% year-over-year, driven by strength in several categories...
AstraZeneca says experimental obesity pill safe and tolerable in early-stage trial
AstraZeneca says experimental obesity pill safe and tolerable in early-stage trial
Nov 4, 2024
LONDON, Nov 4 (Reuters) - AstraZeneca ( AZN ) said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an early-stage trial, with side effects consistent with the GLP-1 drug class. The Phase I trial - which had 72 participants - was designed to assess the safety and tolerability of the pill, as is...
Update: Ford October Vehicle Sales up 15.2% From a Year Earlier
Update: Ford October Vehicle Sales up 15.2% From a Year Earlier
Nov 4, 2024
10:22 AM EST, 11/04/2024 (MT Newswires) -- (Updates with additional details in the third and fourth paragraph, and latest stock movement in the fifth paragraph.) Ford Motor ( F ) said Monday it sold 172,756 vehicles in October, a 15.2% gain from the same period in 2023. Electric vehicle sales in October were down 8.3% at 6,264, while hybrid and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved